Results 281 to 290 of about 290,432 (308)

P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke

Current Neuropharmacology, 2018
Yujie Chen, Hua Feng
exaly  

Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 1

Recent Patents on Anti-Cancer Drug Discovery, 2021
exaly  

Regorafenib/unspecified programmed-cell-death-1-receptor-antagonists

Reactions Weekly, 2023
openaire   +1 more source

A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction

American Journal of Physiology - Renal Physiology, 2019
Anne-Lise Rossi, Chun-Shiang Chung, Eleanor A Fallon   +2 more
exaly  

Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1–high T cells

Journal of Allergy and Clinical Immunology, 2016
Jong Hoon Kim, Young Joon Choi, Jihye Kim   +2 more
exaly  

Gemcitabine/paclitaxel/programmed cell death-1 receptor antagonists

Reactions Weekly, 2021
openaire   +1 more source

Programmed Cell Death of Embryonic Motoneurons Triggered through the FAS Death Receptor

Journal of Cell Biology, 1999
Cedric Raoul, Brigitte Pettmann
exaly  

Panobinostat/programmed cell death-1 receptor antagonists

Reactions Weekly, 2019
openaire   +1 more source

Durvalumab/ipilimumab/programmed cell death 1 receptor antagonists

Reactions Weekly, 2020
openaire   +1 more source

Spatiotemporal Control of CNS Myelination by Oligodendrocyte Programmed Cell Death through the TFEB-PUMA Axis

Cell, 2018
Lu O Sun, Qingyun Li, David J Simon
exaly